Hint mode is switched on Switch off

Teva Pharmaceutical Industries, ordinary share
TEVA, IL0006290147

Add a stock to WL
Choose all Reset all
Teva Pharmaceutical Industries, сountry — Israel
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Issuer

Profile
Teva Pharmaceutical Industries Ltd., is a global pharmaceutical company. The Company develops, manufactures, and markets generic and branded human pharmaceuticals as well as active pharmaceutical ingredients.
  • Issuer
  • Full borrower / issuer name
    Teva Pharmaceutical Industries Limited
  • Industry
    Pharmaceutical Preparation and Biotechnology

IFRS/US GAAP reports

2026
I q eng
2025
I q eng
II q eng
IV q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
I q eng
II q eng
III q eng
IV q eng
2018
I q eng
II q eng
III q eng
IV q eng
2017
IV q eng
2016
IV q eng
2015
IV q eng
2014
IV q eng
Show all Hide

Related Stock indices

Indicators

News

29/04/2026 Teva Pharmaceutical Industries: Results Of Operations And Financial Condition, Regulation Fd Disclosure, Financial Statements And Exhibits
30/01/2026 Teva Pharmaceutical Industries: A Strong Contender in the Pharmaceutical Industry
10/12/2025 Teva Pharmaceutical Industries: Entry Into A Material Definitive Agreement, Creation Of A Direct Financial Obligation Or An Obligation Under, Financial Statements And Exhibits
06/11/2025 Teva Shares Soar 17% After Strong Q3 Results and Raised Outlook on AUSTEDO Growth
05/06/2025 Teva Pharmaceutical Industries: Submission Of Matters To A Vote Of Security Holders
All organization news

Other stocks and deposit receipts

Domestic and international bonds of the issuer

Show all

Holders

Industry Leaders

Registration is required to get access.